Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07569588
Improving Patient Assessment After Acute Kidney Injury (AKI)University Hospitals of Derby and Burton NHS Foundation TrustRecruiting
NCT07569588Recruiting
—
Improving Patient Assessment After Acute Kidney Injury (AKI)University Hospitals of D...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research PlatformsCenter for Molecular Fingerprinting Research Nonprofit LLCNot Yet Recruiting
NCT07570667Not Yet Recruiting
—
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promo...Center for Molecular Fing...
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07571174
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07571174Not Yet Recruiting
Phase 1
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclero...Eli Lilly and Company
NCT07569731
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico RizzoliRecruiting
NCT07569731Recruiting
—
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico Rizzo...
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07569692
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography)-2CardioVascular Research Foundation, KoreaNot Yet RecruitingNot Applicable
NCT07569692Not Yet Recruiting
Not Applicable
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulne...CardioVascular Research F...
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571902
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07571902Not Yet Recruiting
Not Applicable
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569614
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery.First Affiliated Hospital of Kunming Medical UniversityCompletedNot Applicable
NCT07569614Completed
Not Applicable
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative...First Affiliated Hospital...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed3 (15%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 13 (15%)
Phase 41 (5%)